KR101667739B1 - Formentation room for eliminating toxin and elimination method of toxin using thereof - Google Patents

Formentation room for eliminating toxin and elimination method of toxin using thereof Download PDF

Info

Publication number
KR101667739B1
KR101667739B1 KR1020150050605A KR20150050605A KR101667739B1 KR 101667739 B1 KR101667739 B1 KR 101667739B1 KR 1020150050605 A KR1020150050605 A KR 1020150050605A KR 20150050605 A KR20150050605 A KR 20150050605A KR 101667739 B1 KR101667739 B1 KR 101667739B1
Authority
KR
South Korea
Prior art keywords
layer
weight
facility
composition
pine
Prior art date
Application number
KR1020150050605A
Other languages
Korean (ko)
Other versions
KR20160121101A (en
Inventor
이강문
이정애
Original Assignee
이강문
이정애
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이강문, 이정애 filed Critical 이강문
Priority to KR1020150050605A priority Critical patent/KR101667739B1/en
Publication of KR20160121101A publication Critical patent/KR20160121101A/en
Application granted granted Critical
Publication of KR101667739B1 publication Critical patent/KR101667739B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00Bathing devices for special therapeutic or hygienic purposes
    • A61H33/06Artificial hot-air or cold-air baths; Steam or gas baths or douches, e.g. sauna or Finnish baths
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/08Warming pads, pans or mats; Hot-water bottles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Rehabilitation Therapy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

More particularly, the present invention relates to a method for treating or preventing toxicity using a fomenting facility comprising a ceiling portion, a wall portion and a bottom portion, Wherein the bottom comprises a mineral layer consisting of ceramic balls, chalcopyrite, elvan, germanium, octal, tourmaline, mica and olivine, a first pine layer located above the mineral layer, A second pine leaf layer positioned on the upper part of the mugwort layer, and a fabric layer positioned above the second pine nacre layer, wherein the poultice facility, the therapeutic or preventive composition for potable toxicity and the composition for external application The composition is used to prevent toxicity by environmental hormones accumulated in the body and to improve skin diseases.

Description

Technical Field [0001] The present invention relates to a fomentation facility for protecting the body from toxicity and a method for treating or preventing toxicity using the facility,

The present invention relates to a fomenting facility for protecting the body from toxicity and a method for treating or preventing toxicity using the facility. More particularly, the present invention relates to a fomentation facility using minerals, pine needles, wormwood, , A treatment or prevention composition for drinking toxicity, and a composition for external application, which are used to protect or prevent the toxicity caused by environmental hormones accumulated in the body, to improve the skin diseases, and to protect the body from toxicity ≪ / RTI >

An endocrine disruptor is a chemical that interferes with or disrupts the normal function of the endocrine system and is called an endocrine disruptor. It is generally called an environmental hormone.

The environmental hormones act on the endocrine system of the human body and act like female hormones to block hormones, to over-secrete, to over-secrete, infertility, sexual dysfunction, and sperm counts are likely to cause abnormalities such as reproductive dysfunction. Exposure to these factors also causes weight loss, growth retardation, hepatotoxicity, testicular cancer, diabetes, diabetes, impaired immune function, hyperlipidemia, urethral discomfort, latency and malformations, and even in wild animals, genital anomalies, , Heterosexual intercourse, reduction in the number of litters, and male females.

These environmental hormones, unlike biohormones, are not readily degraded and remain in the environment and the body for many years and have been reported to be enriched in the fats and tissues of living organisms such as the human body (Golden, RJ, et al., Crit. Toxicol., 28, pp109-227, 1998; Soto, AM, et al., Environ. Health Perspect, 92, pp167-173, 1991).

As environmental hormones have been raised for the first time in the 1970s, the seriousness of the disease has been on the rise until the mid-1990s, and the controversy over the harmfulness and toxicity of environmental hormones has continued. Since then, we have systematically studied environmental hormones. As of 1998, we have 69 species in the United States and 67 species in the EU and Japan, respectively, as environmental hormone-capable substances. A total of 67 species are estimated to be environmental hormones.

Chemical substances known as environmental hormones include dioxin (TCDD), PCB, DDT, alkyl phenol as a raw material for synthetic detergent, and bisphenol A as a raw material for plastics that are generated when burning garbage. Especially, - 2,3,7,8-Tetrachlorobenzo-P-dioxin (TCDD), a by-product produced in the course of the synthesis of dichlorophenoxyacetic acid, is a tandem environmental hormone belonging to chlorinated aromatic hydrocarbons. Many people who have been exposed to it have suffered so far.

In addition, environmental hormones have been detected in all areas of everyday life such as household cleaners, insecticides, herbicides, automobile soot, disposable tableware made of polystyrene (cup noodle containers), canned beer, canned drinks and even baby bottles.

Therefore, there is a need for aggressive countermeasures to regulate the production of substances containing environmental hormones and to develop alternative substances and methods to escape the harm of environmental hormones. In addition, there is a desperate need for a way to alleviate or protect the toxicity.

On the other hand, atopy is the name of 'Coca' in the United States of America in 1925 for 'congenital irritability' of certain kinds of substances that are peculiar to humans. Allergic diseases, including atopic dermatitis, allergic asthma and rhinitis, account for more than 20% of the world's population.

In particular, there are more than 50 million allergic patients in the US alone, and the market for antihistamines consumed by them is about $ 5 billion a year. According to data on domestic atopic dermatitis, the number of children with atopic dermatitis in children aged 7 years or older has increased more than 10 years ago in Korea with the rapid increase of allergic diseases. There are some cases in which children are naturally healed after passing through the days of infants or children, but in recent years they have been able to continue their smooth social life from birth through adolescence to adolescence.

These atopic dermatitis was known to be caused by disordered diet and stress, but recently, the relationship between environmental hormones, atopic dermatitis and psoriasis has been confirmed.

In other words, the analysis of atopic dermatitis and psoriasis patients' skin revealed that the expression of the environmental hormone receptor, AhR-related genome, was increased in these skin compared to normal skin. AhR is a receptor that is involved in cell development, growth and reproduction in the cell surface, and is known to be associated with allergies and autoimmune diseases. As described above, the increase in AhR and related genes in atopic and psoriatic skin can be interpreted as a combination of environmental hormones such as dioxin (TCDD) and polychlorinated biphenyls (PCBs) and AhR, resulting in atopic dermatitis and psoriasis . These findings are published in the February issue of the European Journal of Immunology and the Dermatology of Experimental Dermatology.

In order to treat atopic dermatitis, steroids, antihistamines, corticosteroids and antibiotics are used when they become secondary infections. However, they are mainly used as ingredients in the pharmaceutical field. In the field of cosmetics, mainly moisturizing effect It is only approaching the concept of alleviating the dryness of atopic skin rather than the treatment of disease mainly by using excellent active substance.

In addition, a poultice facility for the development of various skin diseases such as atopic dermatitis or toxicity of the body has been developed. However, such a poultice facility is limited to the use of only loess.

KR 10-2005-0074071 A KR 10-0840391 B1 KR 10-1997-0061229 A

Accordingly, an object of the present invention is to provide a poultice facility using mineral substances, pine needles, wormwood, and yellow loam in order to protect or release the toxicities accumulated in the body by the above-mentioned environmental hormones and to improve skin diseases such as atopic dermatitis .

By providing a composition for treatment or prevention of poisonous substances which can be consumed together with such a fomenting facility and a composition for external application for skin, it is possible to protect and excrete the toxicity of environmental hormones, especially dioxin, as well as to alleviate inflammation and to provide atopic dermatitis, It is aimed to improve various skin diseases such as psoriasis.

A fomenting facility for protecting the body from toxicity according to the present invention is a fomentation facility comprising a ceiling part, a wall part and a bottom part, and an indoor space capable of fomenting, wherein the bottom part comprises ceramic balls, And a mineral layer composed of octane, tourmaline, mica stone and olivine.

A first pine leaf layer positioned above the mineral layer, a mugwort layer located above the first pine leaf layer, a second pine needles layer positioned above the mugwort layer, Further comprising:

Wherein the mineral layer comprises 5 to 15% by weight of ceramic balls, 2 to 8% by weight of gypsum, 5 to 15% by weight of elvan, 20 to 40% by weight of germanium, 5 to 15% by weight of tourmaline, 5 to 15% 2 to 8 wt%, and olivine 5 to 15 wt%.

And an inner side surface of the wall portion is formed of a clay soil layer.

The method for treating or preventing toxicity using the above-described fomentation facility includes a hot water extract of a natural material, such as ginger, licorice, moss, kelp, gilt roots, ginseng roots, The method comprising the steps of: drinking a composition for treating or preventing potable environmental hormone toxicity, fomenting the feces for 30 to 120 minutes using the fomentation facility, and extracting the feces with a alcohol, And a step of mixing the first liquid as an alcohol extract and the second liquid as a mixture of peppermint oil, sulfur and sulfur into an alcohol in an amount of 3 to 5: 1 part by weight and applying the mixture to the affected part of the skin disease.

According to the fomenting facility of the present invention, various minerals and chelating agents are generated from pine needle, wormwood, yellow clay, etc. contained in the fomentation facility, and these various components are absorbed into the body through the pores through osmotic action, Heavy metals, toxic substances, bacteria, etc. are melted to be sweated and excreted in the urine, and the effect of relieving inflammation is provided.

In addition, the release of such toxicity and the relief of inflammation provide an effect of improving various dermatitis such as atopic dermatitis.

In addition to such a fomenting facility, a composition for treating or preventing a toxic substance that can be consumed is applied, and a composition for external application for skin is applied to the affected area, thereby remarkably protecting the environment hormone, especially dioxin, and maximizing the improvement of various dermatitis to provide.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a view of a fomenting facility showing an embodiment of the present invention. FIG.
2 is a view showing a fomenting facility showing another embodiment according to the present invention.
3 is a view showing a fomenting facility having a dome-shaped wall portion and a ceiling portion according to the present invention.

Hereinafter, the present invention will be described in detail.

First, explain the poultice facilities that help to protect the accumulated toxins in the body.

As shown in FIG. 1, the fomenting facility according to the present invention includes a ceiling portion 30, a wall portion 20, and a bottom portion 10, and includes a space S, . In addition, although it is not shown in the drawing, it is natural that a door for entrance and exit of a person is provided separately.

At this time, the bottom portion 10 is composed of a heating means layer 11 having a heating means and a mineral material layer 12 located above the heating means layer 11.

The heating means layer 11 may be an electric panel in which a heating wire used for heating a fomenting facility is buried, a hot water panel in which a hot water pipe is embedded, and the like. In addition, the heating means layer 11 is heated and maintained at a temperature of about 55 to about 60 DEG C so that effective materials are generated in the fomentation facility and far-infrared rays can be radiated.

1, but the heating means layer 11 may be used as a cushion and may have a separate firebox and a chimney at one side of the fomenting facility. In this case, But does not limit its implementation.

A mineral layer 12 is disposed on the heating means layer 11. The mineral layer 12 is composed of ceramic balls, chalks, elvan, germanium, octal, tourmaline, mica and olivine.

Here, the ceramic ball is a product formed by molding an inorganic material into a ball shape and then processing and molding it at a high temperature. It does not limit the type of ceramic used, the size of the ball, the firing temperature, and the like, For example, a porous ceramic ball made of hydroxyapatite can be used. In addition, the ceramic balls emit a large amount of negative ions, and the far infrared rays are radiated to improve the blood circulation of the human body, and to help heal wounds and discharge toxins.

The above-mentioned jewels, elvan, germanium, octal, mica stone and olivine are also minerals emitting much far-infrared rays. Far infrared rays penetrate up to 40 mm in the skin to expand the capillary blood vessels of the human body to facilitate blood circulation and promote metabolism It helps to release toxins. Among them, mica stone has proved its anticancer and antiviral effect and produces interferon and has anti-cancer effect.

Tourmaline is a mineral that emits a large amount of anions as well as far-infrared rays. It also inhibits the activity of active oxygen in the body through anions and has an antioxidant effect to prevent aging. It further activates blood circulation and metabolism, And an immunity-increasing effect.

The mineral layer 12 made up of these minerals is composed of 5 to 15 wt% of ceramic balls, 2 to 8 wt% of fullerenes, 5 to 15 wt% of elvan, 20 to 40 wt% of germanium, 5 to 15 wt% To 15% by weight of mica, 2 to 8% by weight of mica and 5 to 15% by weight of olivine. The emission ratio of the far-infrared rays and anions of the far-infrared rays can be maximized through this composition ratio.

2 and 3, the bottom 10 of the feminine napkin according to the present invention includes a first pine layer 13 positioned above the mineral layer 12 and a second pine layer 13 located above the first pineapple layer 13, A second pine nacre layer 13 'positioned above the warp layer 14 and a fabric layer 15 positioned above the second pine nacre layer 13' .

At this time, since the first pine leaf layer 13 and the second pineapple layer 13 'contain a large amount of apiarying acid, it is possible not only to help detoxification and release of nicotine, It lowers the level of toxicity and helps prevent various adult diseases. It also helps blood circulation and purifies blood, which is good for arteriosclerosis and prevention of hypertension. At this time, the thicknesses of the first pine nave layer 13 and the second pineapple layer 13 'are not limited, but are most preferably 4 cm to 6 cm.

In the mugwort layer (14), an essential oil component called cineol forms a thin film on the skin to help the system blood circulation. The chlorophyll improves blood circulation and enlarges the peripheral blood vessels, thereby discharging waste products and toxins in the body . The mugwort layer 14 is not limited in its thickness, but is preferably formed to have a thickness of about 0.3 to 1 cm.

The reason why the fabric layer 15 is provided on the second pine needle layer 13 'is that when the second pine needle layer 13' comes into direct contact with the surface of the skin of the user using the padding system, This is because it is not good and you can feel discomfort in the padding. Therefore, it is preferable to use a cotton fabric which is natural fiber excellent in feel and feel without inducing allergies, skin diseases and the like as the fabric layer 15.

Meanwhile, the inner surface of the wall portion 20 of the fomenting facility according to the present invention is preferably composed of the clayey layer 21, radiating a large amount of far-infrared rays through the clayey layer 21, adjusting the humidity in the fomentation facility , Antibacterial, detoxification, inflammation elimination, and discharging of heavy metals, thereby helping to release toxic substances accumulated in the body by environmental hormones and the like.

In addition, one or more herbal medicine pouches 40 may be further provided in the fomentation facility, and the herb medicine sachets 40 may be provided with mugwort or pine needles. At this time, the position of the herbal medicine bag 40 is not limited, and it may be hooked on a wall surface as shown in FIGS. 2 and 3, or may be placed on a floor surface.

3, the wall portion 20 and the ceiling portion 30 may be formed in a dome shape without being distinguished from each other, and the shape of the dome portion is not limited.

It is preferable that the fomenting facility constructed as described above is used for 30 to 120 minutes, and the internal temperature is preferably maintained at 55 to 65 ° C.

When the above-mentioned fomentation facility is used, various components are absorbed into the body through osmotic action, and various heavy metals and toxic substances accumulated in the body are discharged into sweat and urine, and at the same time, the inflammation is mitigated by sterilizing action.

Hereinafter, a method for treating or preventing toxicity using the facility will be described.

The present invention can use the above-described fomentation facilities alone, but it is also possible to treat or prevent the accumulated toxicity in the body by using a composition capable of drinking and a composition for external application for skin.

Hereinafter, the method will be described in detail.

The present invention relates to a method of drinking or drinking a composition for treating or preventing a potentially harmful environmental hormone toxin comprising, as an active ingredient, a hot water extract of a natural material consisting of ginger, licorice, moss, kelp, gilt roots, celestial vine roots, step.

First, 100 parts by weight of ginger, 100-150 parts by weight of licorice, 100-150 parts by weight of moss, 100-150 parts by weight of kelp, 100-200 parts by weight of rootstock, 80-120 parts by weight of rootstock, 80 to 120 parts by weight of Rhus root and 80 to 120 parts by weight of elm roots are prepared, and 3 to 20 times as much water is added thereto as a volume ratio, and the mixture is heated at 90 to 100 DEG C for 5 to 6 hours to extract an active ingredient .

Then, it is heated at 70 to 80 ° C for 5 to 7 hours to prepare a concentrate having a solid content of 15 to 34%.

When the concentrated concentrate is used at a dose of about 300 cc for 60 kg adult, more preferably about 200 cc for morning and 100 cc for afternoon cure, the concentrate can effectively excrete toxic substances in the body by environmental hormones and effectively improve atopic dermatitis I can do it.

And then fomenting for 30 to 120 minutes using the fomentation facility.

After drinking the composition for treating or preventing environmental hormone toxicity, which can be consumed as described above, it is foment for 30 to 120 minutes using the above-described fomentation facility.

When the composition for treatment or prevention of toxicity is soaked in water and then fomentation is performed, the effect of the fomentation is further maximized, and the effect of discharging toxic components in the human body through sweat as the sweat is discharged by the fomentation doubles.

In addition, various kinds of dermatitis are alleviated through the above-mentioned fomentation.

The first liquid is an alcoholic extract obtained by extracting aloe with alcohol, and the second liquid, which is alcohol, is a mixture of 3 to 5: 1 part by weight of peppermint oil, To the affected area.

Finally, the first liquid is an alcoholic extract obtained by extracting Aloe with Aloe, and the second liquid is a mixture of Alcohol and Mucor, and the second liquid is 3 to 5: 1 part by weight. Apply to the affected area.

Wherein the first liquid comprises 1 to 5 parts by weight of Aspergillus oryzae, 1 to 5 parts by weight of a sweet potato, 1 to 5 parts by weight of an eggplant, 1 to 5 parts by weight of oat, 1 to 5 parts by weight of aloe, Lt; / RTI >

The second solution is prepared by mixing 1 to 5 parts by weight of peppermint oil with 100 parts by weight of alcohol, and then adding 1 to 5 parts by weight of sulfur and 1 to 5 parts by weight of a confectionery.

When such a composition for external application for skin is applied, toxicity is excreted in the body by the poultice and the pores are opened, so that the composition of the present invention penetrates deeper and the action of improving inflammation is more excellent.

Hereinafter, the present invention will be described with reference to specific examples.

(Example)

Manufacture of poultice facilities

10 parts by weight of gypsum, 10 parts by weight of gypsum, 30 parts by weight of germanium, 10 parts by weight of tourmaline, 10 parts by weight of tourmaline, 10 parts by weight of mica stone, 5 parts by weight of mica stone and 10 parts by weight of olivinic stone, and a heating means to become a hot water mat at the lower part of the mineral material layer. On top of the mineral layer, a pine layer was laid down to a thickness of 5 cm, a mugwort was laid on the layer to a thickness of 0.5 cm, and then the pine layer was laid down to a thickness of 5 cm. And finally, we laid cotton fabrics. The inner surface of the wall portion of the fomenting facility was covered with yellow soil to provide an ocher layer, and the internal temperature of the fomentation facility was set to 60 ± 5 ° C.

Preparation of a drinkable composition

5 liters of water was added thereto, and the mixture was heated at 90 to 100 DEG C for 6 hours to extract an active ingredient.

The extracted extract was heated at 70 to 80 ° C for about 5 hours to obtain a concentrate having a solid content of 20%.

Mixing Ratio of Examples ginger 100 licorice 130 Moss 150 Kelp 130 Roots 150 Root of Vine Root 100 Sorrow 100 Lacquer root 100 Elm root 100

Preparation of composition for external application

Examples were prepared at the blending ratios shown in Table 2 below.

At this time, the first liquid was prepared by immersing the materials in alcohol for 4 days and then removing the material. The second liquid was prepared by first mixing the peppermint oil with alcohol and then mixing the sulfur and the saponin. The first solution and the second solution were mixed at a weight ratio of 4: 1.

Formulation ratio (g) of composition for external application The first sum




Alcohol 1000
Sorrow 25 Sat Bokryeong 25 Anchor 25 Oylum 25 Aloe 25 Second sum


Alcohol 1000
peppermint oil 25 brimstone 25 An inspiration 25

(Test Example 1) Test for atopic dermatitis

Twenty children aged 20 to 30 years with atopic dermatitis were divided into four groups. Each group was used as a feminine pouch for the group 1, and the feminine pouch was used for only 60 minutes for the group 1, In the other group, a composition capable of drinking once a day was ingested in an amount corresponding to 5 cc / kg, and then the fomentation facility was used for 60 minutes. In Example 3, one group was allowed to drink a composition which was once drinkable once a day, After the facility was used for 60 minutes, the composition for external application was applied to the affected area. And the other group, as a control group, took no action.

After 30 days, the effect on atopic dermatitis was quantified in four stages: very effective, slightly effective, ineffective, and worse. The results are shown in Table 3 below.

Results for Test Example 3. division Control group Example 1 Example 2 Example 3 Very effective 0 0 2 5 Slight effect 0 3 3 0 no effect 5 2 0 0 worse 0 0 0 0

As can be seen from the above Table 3, the fomentation facility of the present invention showed excellent symptom improvement effect on atopic dermatitis. In addition, it was confirmed that Example 2 using this composition together with a drinkable composition, and Example 3 using the composition capable of drinking, a fomenting facility, and a composition for external application showed more excellent effects.

(Test Example 2) Test for contact dermatitis

Twenty adults aged 20 to 30 years with contact dermatitis were divided into four groups and tested in the same manner as in Test Example 1 above. After 10 days, the effects on contact dermatitis were quantified in four steps: very effective, slightly effective, ineffective, and worse. The results are shown in Table 4 below.

Results for Test Example 2. division Control group Example 1 Example 2 Example 3 Very effective 0 0 One 3 Slight effect 0 3 4 2 no effect 5 2 0 0 worse 0 0 0 0

As can be seen from Table 4, the fomenting facilities of the present invention showed excellent symptom improvement effect on contact dermatitis. In addition, it was confirmed that Example 2 using this composition together with a drinkable composition, and Example 3 using the composition capable of drinking, a fomenting facility, and a composition for external application showed more excellent effects.

(Test Example 3) Test for eczema

Twenty adults aged 20 to 30 years with eczema were divided into 4 groups and tested in the same manner as in Test Example 1 above.

After 10 days, the effects on eczema were quantified in four stages: very effective, slightly effective, ineffective, and worse. The results are shown in Table 5 below.

Results for Test Example 3. division Control group Example 1 Example 2 Example 3 Very effective 0 0 One 2 Slight effect 0 4 3 3 no effect 3 One One 0 worse 2 0 0 0

As can be seen from Table 5, the fomentation facility of the present invention showed excellent symptom improvement effect on eczema. In addition, it was confirmed that Example 2 using this composition together with a drinkable composition, and Example 3 using the composition capable of drinking, a fomenting facility, and a composition for external application showed more excellent effects.

(Test Example 4) Detoxification effect of dioxin.

Eight adults who responded that they were exposed to Agent Orange, that is, dioxin, who were 65 to 70 years old and were exposed to dioxins, were used as Example 1 and fired for 2 minutes only once daily for 60 minutes , And the other two persons as Example 2 were drunk with the amount of the drinkable composition prepared as described above once per day in an amount corresponding to 5 cc / kg, and then the fomentation facility was used for 60 minutes. In Example 3, The drinkable composition was drunk, the fomenting facility was used for 60 minutes, and then the external application composition was applied to the affected area. However, the composition for external application is not limited and is applied a plurality of times a day. And the other two as controls did not take any action. This was repeated for 30 days.

After 30 days, the blood was collected, and the serum was separated using a centrifuge for blood biochemical analysis. The blood was analyzed using an automatic blood biochemical analyzer Dimension (Dupont, USA) And then analyzed using CellDyn (Abbott, USA), an automatic hematology analyzer.

The results are shown in Tables 6 and 7 below.

Results for Test Example 4. division Standard group Comparative Example 1 Example 1 Example 2 Example 3 Leukocytes (1.0 x 10 < 3 > / ul) 7.07 ± 1.62 4.21 ± 1.30 4.51 ± 0.87 5.27 ± 0.52 6.87 ± 0.71 Red blood cells (1.0 x 10 < 6 > / ul) 0.31 + - 4.82 4.94 + - 0.46 4.91 + - 0.52 4.84 ± 0.17 4.79 ± 0.20 Platelets (1.0 x 10 < 3 > / ul) 7.26 ± 0.92 5.67 ± 0.62 5.91 + - 0.54 6.21 + - 0.41 6.62 + - 0.60 Hemoglobin (a / dl) 13.3 ± 0.8 14.0 ± 0.9 13.9 ± 0.7 13.7 ± 0.2 13.5 ± 0.5 Hematocrit (%) 41.1 ± 0.18 41.5 ± 2.2 41.3 ± 1.5 40.5 ± 1.5 39.5 ± 1.5

As shown in Table 6, it can be seen that Examples 1 to 3 are closer to those of normal group in comparison with Comparative Example 1 in leukocyte, erythrocyte, platelet, hemoglobin and the like. In addition, it was confirmed that Example 3 is closer to the standard group than Examples 1 and 2.

Results for Test Example 4. division Standard group Comparative Example 1 Example 1 Example 2 Example 3 Glucose (mg / dl) 135 ± 19 166 ± 44 154 ± 31 125 ± 27 119 ± 20 Amylase (ul / L) 3652 ± 187 5115 ± 260 4987 ± 152 4871 ± 235 4725 ± 238 Cholesterol (mg / dl) 33.6 ± 5.7 49.4 ± 11.0 47.2 ± 3.50 47.3. + -. 4.87 42.3 ± 5.3 Triglyceride (mg / dl) 29.4 ± 6.7 86.7 ± 17.5 70.4 ± 0.5 65.8 ± 3.1 61.7 ± 14.1 HDL-cholesterol (mg / dl) 1.73 ± 0.88 2.40 ± 1.06 2.71 ± 1.5 2.51 ± 1.4 2.67 ± 1.59 Lipase (lu / L) 15.6 ± 10.9 43.4 ± 8.0 38.5 ± 2.5 20.7 ± 3.2 3.8 ± 2.2

As shown in Table 7, glucose and amylase were significantly increased in Comparative Example 1, but it was confirmed that Examples 1 to 3 of the present invention were as close to the standard control as possible.

In addition, the activity of cholesterol content, triglyceride and Lapase was increased in Comparative Example 1, but it was confirmed that the activity increase was suppressed in Examples 1 to 3.

In addition, the activities of GOT and GPT were increased to 189.2% and 133.5%, respectively, in the case of Comparative Example 1, but the activity of GOT was 111% in the case of Example 3, and the activity of GPT was 111% To 102% level.

Therefore, it has been confirmed that the method according to the present invention is capable of protecting against toxicity of dioxin, i.e., treating or preventing.

Since environmental hormones are known to cause similar toxicity by the same functional group, the present invention is not limited to dioxins, and its clinical application also affects the detoxification and prevention of other types of environmental hormones and the expression of toxins something to do.

While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the scope of the present invention is not limited to the disclosed exemplary embodiments. It will also be appreciated that many modifications and variations will be apparent to those skilled in the art without departing from the scope of the present invention.

10: bottom part 20: wall part 30: ceiling part
40: Herb pouch
11: heating means layer 12: mineral layer 13: first pine layer
13 ': second pineal layer 14: rapier layer 15: fabric layer
21: Horticulture

Claims (5)

1. A feminine nursing facility comprising a ceiling part (30), a wall part (20), and a bottom part (10) and provided with an indoor space part (S)
The bottom part 10 is provided with a heating means layer 11 having a heating means and a heating means layer 11 located above the heating means layer 11 and made of a ceramic ball, chum, elvan, germanium, A first pineal layer 13 located above the mineral layer 12, a mugwort layer 14 located above the first pineal layer 13, A second pine layer 13 'located above the layer 14 and a fabric layer 15 located above the second pineapple layer 13'
The mineral layer 12 comprises 5 to 15% by weight of ceramic balls, 2 to 8% by weight of gypsum, 5 to 15% by weight of elvan, 20 to 40% by weight of germanium, 5 to 15% 2 to 8% by weight of mica and 5 to 15% by weight of olivine,
The fabric layer 15 becomes a cotton fabric,
The inside of the wall part 20 is constituted by the clay soil layer 21,
Wherein the herbal composition bag (40) further comprises at least one herb medicine bag (40) in the fomenting facility, and the herb medicine bag (40) comprises wormwood or pine needle.
delete delete delete delete
KR1020150050605A 2015-04-10 2015-04-10 Formentation room for eliminating toxin and elimination method of toxin using thereof KR101667739B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020150050605A KR101667739B1 (en) 2015-04-10 2015-04-10 Formentation room for eliminating toxin and elimination method of toxin using thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150050605A KR101667739B1 (en) 2015-04-10 2015-04-10 Formentation room for eliminating toxin and elimination method of toxin using thereof

Publications (2)

Publication Number Publication Date
KR20160121101A KR20160121101A (en) 2016-10-19
KR101667739B1 true KR101667739B1 (en) 2016-10-20

Family

ID=57250562

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150050605A KR101667739B1 (en) 2015-04-10 2015-04-10 Formentation room for eliminating toxin and elimination method of toxin using thereof

Country Status (1)

Country Link
KR (1) KR101667739B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR200180419Y1 (en) 1997-10-27 2000-05-01 김석재 A Structure of Fomenting Ocher Room with Wormwood and Pine Needles
KR100636631B1 (en) 2005-10-07 2006-10-19 정명영 Light-weight charcoal oven and construction method thereof
KR101468477B1 (en) 2013-05-29 2014-12-04 (주)메덱스 Dome apparatus for stupe

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970061229A (en) 1996-02-21 1997-09-12 김용철 Hwangtoj steam room and fomentation method using it
KR100637358B1 (en) 2004-01-13 2006-10-20 재단법인서울대학교산학협력재단 Composition comprising the extract of Glycyrrhizae radix for preventing the toxicity of Endocrine Disruptors
KR100840391B1 (en) 2005-10-19 2008-06-23 변무원 A pharmaceutical agent for ameliorating symptoms of atopic dermatitis containing refining wood vinegar
KR20120005993U (en) * 2011-02-17 2012-08-27 유유자 Chair having fomentation function

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR200180419Y1 (en) 1997-10-27 2000-05-01 김석재 A Structure of Fomenting Ocher Room with Wormwood and Pine Needles
KR100636631B1 (en) 2005-10-07 2006-10-19 정명영 Light-weight charcoal oven and construction method thereof
KR101468477B1 (en) 2013-05-29 2014-12-04 (주)메덱스 Dome apparatus for stupe

Also Published As

Publication number Publication date
KR20160121101A (en) 2016-10-19

Similar Documents

Publication Publication Date Title
US20060269567A1 (en) Universal detoxifying composition
CN1679888A (en) Decoction Chinese medicine sterilizing antiphlogistic, preparation and use thereof
KR101653332B1 (en) Bio Pad
WO2008072988A1 (en) Honey based compositions of a consistency that can be delivered to the respiratory system
CN101856384A (en) Liver-protecting combination
KR101667739B1 (en) Formentation room for eliminating toxin and elimination method of toxin using thereof
CN102846991A (en) Ointment for treating burn or scald
Bok et al. Safety of 8-weeks oral administration of Arctium lappa L.
Khan et al. A Review-Benefits of Panchgavya therapy (Cowpathy) for health of humans
US8591960B2 (en) Composition and method for treating bedsores, cuts and burns
KR100793815B1 (en) Method for removing toxic ingredients
KR101654285B1 (en) Sanitary pad containing the phytoncide
KR20150078613A (en) Anti-allergy composition comprising the extracts of aloeswood and concentratedunderground water as an active ingredient
CN104056218A (en) Medicine for treating skin diseases and preparation method of medicine
CN1660264A (en) Combination of Chinese traditional for feet bath and preparation method
KR101667738B1 (en) Composition for Preventing or relaxting Toxicity of an Environmental Hormone and manufacturing method therof
Mohajeri et al. Comparison of the effect of normal saline and silver sulfadiazine on healing of skin burn wounds in rats: A histopathological study
CN102008586A (en) Effective drug for treating skin disease
CN106359480A (en) Efficient insecticide disinfector
KR20160121100A (en) External Compositions for treating skin diseases, manufactuing method thereof and treatment method of skin diseases using therof
KR100977650B1 (en) Compunds and producing process for enzyme bath
CN1970020B (en) A pharmaceutical composition, preparation process and application thereof
KR102665279B1 (en) ION PlASTER MANUFACTURING METHOD FOR HUMAN AND PET, COMPOSITION THEREOF, AND ITS PRODUCT
KR101148848B1 (en) Functionality sheet for car ceiling-sheet
Abood et al. Evaluation of the Antidiabetic Activity of a Traditional Herbal Mixture in Alloxan Induced Diabetic Rabbits

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant